EGFR signaling is required for oncogenic KRAS-induced pancreatic tumorigenesis [16,17], and EGFR signaling activation also induces upregulation of FASN in pancreatic cancer cells in an ERK-dependent manner [18]. The gene discussed is KRAS; the disease is pancreatic neoplasm.